Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)
INTERVENTIONAL
Inicio: 25 de oct de 2018
ID: NCT03635567
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability and Efficacy of Multiple Sublingual Microdoses of 5-MeO-DMT in Reducing Symptoms of Depression and/or Anxiety.
INTERVENTIONAL
Inicio: 21 de oct de 2024
ID: NCT06816667
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept (MK-7962) Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care
INTERVENTIONAL
Inicio: 14 de nov de 2024
ID: NCT06664801
Reclutando
ClinicalTrials.gov
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
OBSERVATIONAL
Inicio: 1 de ene de 2017
ID: NCT01501838
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.
INTERVENTIONAL
Inicio: 17 de sept de 2015
ID: NCT02545049
Completado
Fase 3
ClinicalTrials.gov
Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction
INTERVENTIONAL
Inicio: 16 de mar de 2021
ID: NCT04788511
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00696436
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Randomized, Double-blind, Multi-center, Parallel LCZ696 on NT-proBNP, Exercise Capacity, Symptoms and Safety Compared to Individualized Medical Management of Comorbidities in Patients With Heart Failure and Preserved Ejection Fraction
INTERVENTIONAL
Inicio: 22 de ago de 2017
ID: NCT03066804
Completado
Fase 3
ClinicalTrials.gov
Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.
INTERVENTIONAL
Inicio: 1 de ago de 2015
ID: NCT02298088
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
INTERVENTIONAL
Inicio: 30 de abr de 2025
ID: NCT06948435
Completado
Fase 3
ClinicalTrials.gov
Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients With Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy With an EGFR Tyrosine Kinase Inhibitor (EGFR-TKI)
INTERVENTIONAL
Inicio: 18 de sept de 2015
ID: NCT02474355
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01076764
Completado
Fase 3
ClinicalTrials.gov
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 17 de jun de 2019
ID: NCT03914326
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
INTERVENTIONAL
Inicio: 20 de nov de 2023
ID: NCT06077864
Completado
Fase 3
ClinicalTrials.gov
A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00282984
Terminado
Fase 3
ClinicalTrials.gov
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
INTERVENTIONAL
Inicio: 23 de ene de 2014
ID: NCT01894022
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease
INTERVENTIONAL
Inicio: 30 de may de 2023
ID: NCT05882045
Terminado
Fase 3
ClinicalTrials.gov
DORADO-EX - A Dose-Blinded, Long-Term Safety Extension Study of Fixed Doses of Darusentan in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-311-E)
INTERVENTIONAL
Inicio: 1 de sept de 2006
ID: NCT00353574
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Study to Evaluate Safety and Tolerability in Patients With Chronic Heart Failure and Reduced Ejection Fraction From PARADIGM-HF Receiving Open Label LCZ696
INTERVENTIONAL
Inicio: 16 de oct de 2014
ID: NCT02226120
Reclutando
ClinicalTrials.gov
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
OBSERVATIONAL
Inicio: 1 de jul de 2024
ID: NCT06573723
Anterior
1
...
17
18
19
...
434
Siguiente
Filtros